Jennifer Quint is a Professor of Respiratory Epidemiology at the National Heart and Lung Institute and Honorary Consultant Physician in Respiratory Medicine at the Royal Brompton and Imperial College London NHS Foundation Trusts.
Dr Quint’s research interests centre on the use of electronic health records to study chronic obstructive pulmonary disease (COPD) as well as other chronic respiratory diseases including asthma, ILD and bronchiectasis. She leads a clinical epidemiology research group whose work centres largely on understanding the relationship between cardiovascular and respiratory disease as well as maximising the quality, linkage and usage of routinely collected data for clinical and research purposes. The majority of her work has been on exacerbations of COPD, exploring both the effect of COPD exacerbations on vascular outcomes and the relationship between environmental factors and exacerbations of COPD.
et al., 2021, Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study., Lancet Digit Health, Vol:3, Pages:e217-e230
et al., 2021, Impact of Covid-19 National Lockdown on Asthma Exacerbations: Interrupted Time Series Analysis of English Primary Care Data, Thorax, ISSN:0040-6376
et al., 2021, Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials, European Respiratory Journal, Vol:57, ISSN:0903-1936, Pages:1-13
et al., 2021, Chronic Obstructive Pulmonary Disease (COPD) in population studies in Russia and Norway: Comparison of prevalence, awareness and management, International Journal of Copd, ISSN:1176-9106
et al., 2021, Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial, International Journal of Copd, ISSN:1176-9106